PMCB
PharmaCyte Biotech, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Joshua N. Silverman
IPO Date
2013-01-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
PharmaCyte Biotech, Inc.
CEO
Joshua N. Silverman
IPO Date
2013-01-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 0 |
| $0.00 |
| 17 Jul 2026 | SCHECHTER JONATHAN | director | J-Other | Acquired | 0 | $0.00 |
| 17 Jul 2026 | WEINSTEIN ROBERT | director | J-Other | Acquired | 0 | $0.00 |
| 2 Apr 2026 | WEINSTEIN ROBERT | director | A-Award | Acquired | 119,170 | $0.67 |
| 2 Apr 2026 | WALKER WAYNE REMELL | director | A-Award | Acquired | 119,170 | $0.67 |
| 2 Apr 2026 | SCHECHTER JONATHAN | director | A-Award | Acquired | 119,170 | $0.67 |
| 2 Apr 2026 | Abecassis Michael M | director | A-Award | Acquired | 119,170 | $0.67 |
| 7 Jan 2026 | Silverman Joshua | director, officer: CEO and President | P-Purchase | Acquired | 30,000 | $0.78 |
| 7 Jan 2026 | Silverman Joshua | director, officer: CEO and President | P-Purchase | Acquired | 30,000 | $0.79 |